Here are relevant reports on : health-and-wellness-market
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Health Ingredients Market by Type (Vitamins, Minerals, Probiotics starter culture, Prebiotics, Nutritional Lipids, Functional Carbohydrates, Plant and Fruit Extracts, Enzymes, Proteins), Application, Source, Function and Region - Global Forecast to 2027
The market for health ingredients is projected to reach USD 146.3 billion by 2027, it is projected to grow at a CAGR of 7.8% during the forecast period. The key players in this market include Archer Daniels Midland Company (ADM) (US), Associated British Foods PLC (UK), International Flavors & Fragrances Inc. (US), Kerry Group PLC (Ireland), DSM (Netherlands), BASF SE (Germany), Cargill Incorporated (US), Ingredion (US), Arla Foods (Denmark), Tate & Lyle (UK), Lonza (Switzerland), Royal FrieslandCampina N.V. (Netherlands), Glanbia PLC (Ireland), CHR Hansen Holdings A/S, (Denmark), and Probi (Sweden). Strategic partnerships were the dominant strategy adopted by the key players, followed by expansions and new product launches. These strategies have helped them to increase their presence in different regions and industrial segments.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Gluten-free Baking Mixes Market by Application (Cookies, Cakes and Pastries, Bread, Pizza, Others), Distribution Channel (Supermarkets & Hypermarkets, Health Food Stores, Convenience & Grocery Stores, Others) and Key Region - Forecasted to 2027
According to MarketsandMarkets, the global Gluten-free baking mixes market is estimated to be valued at USD 477.1 million in 2022. It is projected to reach USD 681.7 million by 2027, with a CAGR of 7.4%, in terms of value between 2022 and 2027. Growth of gluten-free baking mixes market size is expected to be driven by rising awareness around gluten intolerance, with governments approving the gluten-free labels to raise such awareness amongst consumers.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Pilot Health Monitoring Systems Market by Component (Hardware, Software) by Platform (Commercial, Defense) by Implementation (On-premises, Cloud-based) by Sales Channel (OEM, Aftermarket) and Region - Global Forecast to 2030
The major players in the global Pilot Health Monitoring Systems Market
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Udder Health Market by Product (Pharmaceuticals (Antibiotics, Intramammary Infusions), Devices (Milk Quality Analysers), Supplements)), Veterinary Care Settings (Dairy Farms, Veterinary Hospitals & Clinics), Animal Type - Global Forecast to 2029
The global udder health market, valued at US$1.13 billion in 2023, stood at US$1.18 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$1.58 billion by the end of the period. The growth in the udder health market can be attributed to the factors, including increasing investments, funds, and grants by governments and other organizations, rising number of veterinarians in the developing countries.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Animal Health Market by product (Parasiticides (Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive( Vitamin, Amino Acids, Antioxidant), Growth Promoter) Animal (Livestock, Companion), End-user (Hospitals) & Region - Global Forecast to 2025
The global Asia Pacific Animal Health Market in terms of revenue was estimated to be worth $15.6 billion in 2020 and is poised to reach $22.1 billion by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
Microservices in Healthcare Market by Component (Platform, Services (Consulting, Integration, Training, Support, Maintenance)), Delivery (Cloud, Hybrid, Private, On-premise), End User (Health care Provider, Payer, Life Science) - Global Forecast to 2023
The microservices in healthcare market is projected to reach USD 343.3 million by 2023, growing at a CAGR of 21.3%. The benefits of microservice architecture, such as their ability to increase overall efficiency and project delivery speed, are the primary factor driving the market growth. However, concerns regarding security and regulatory compliance and the complexity of architecture are expected to hinder the growth of this market. The microservices in healthcare market is marked by the presence of several big and small players. Prominent players in this market include AWS (US), CA Technologies (US), Microsoft (US), Salesforce (US), Pivotal Software (US), Infosys (India), IBM (US), NGINX (US), Oracle Corporation (US), and Syntel (US).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Companion Animal Health Market by Animal Type (Dogs, Cats), Product (Vaccines, Pharmaceuticals, Diagnostics), End User (Veterinary Hospitals & Clinics, Diagnostics Laboratories) - Global Forecast to 2027
The companion animal health market is projected to reach USD 26.9 Billion by 2027 from USD 19.2 Billion in 2022 at a CAGR of 6.9% during the forecast period. The growth in this market is mainly attributed to increasing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. However, increasing pet care costs are expected to hinder market growth to a certain extent.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Pet Supplements Market by Functional Application (Skin & Coat, Hips & Joints, Digestive Health, Immune Support), Supplement Type (Multivitamin, Glucosamine, Antioxidants), Pet, Form, Distribution Channel, and Region - Global Forecast to 2029
According to MarketsandMarkets, the global pet supplements market is estimated to be valued at USD XXX.X million in 2024 and is projected to reach USD XXX.X million by 2029, recording a CAGR of X.X%. Key players in this market include ADM (US), Nestlé (Switzerland), Nutramax Laboratories, Inc. (US), Zoetis Services LLC (US), Virbac (France), Zesty Paws (US), These players have adopted strategies of product launches, expansions, agreements/partnerships, and mergers and acquisitions to grow in the market. All key product manufacturers that are part of the pet supplements ecosystem have been considered under the company profiles section.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecast to 2026
The global prostate health market growth is primed to transition from USD 31.8 billion in 2021 to USD 48.9 billion by 2026, showcasing a strong CAGR of 9.0%. Growth in this market is primarily driven by the increasing prevalence of benign prostatic hyperplasia, increasing obesity, investments, funds, and grants for research in prostate health, an increase in the prevalence of prostate cancer, a surge in demand for hormone therapy drugs, emerging therapies for prostate cancer, and an increasing incidence of prostatitis.
- Published: December 2021
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
